fig1
![[<sup>18</sup>F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular carcinoma model treated with sorafenib](https://image.oaes.cc/c6dd0c1d-2cff-4b96-b6b0-ba59a9eb9a19/2679.fig.1.png)
Figure 1. Illustrations of histologic and immunohistochemical view of the HCC Grade III Edmondson-Steiner. (A) Hematoxylin-eosin, ×200; (B) glutamine synthetase, ×200; (C) HEP-PAR-1, ×400; (D) CK-19, ×400
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
